BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26631964)

  • 1. MicroRNA-24 inhibits serotonin reuptake transporter expression and aggravates irritable bowel syndrome.
    Liao XJ; Mao WM; Wang Q; Yang GG; Wu WJ; Shao SX
    Biochem Biophys Res Commun; 2016 Jan; 469(2):288-93. PubMed ID: 26631964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin transporter gene promoter region polymorphisms and serotonin transporter expression in the colonic mucosa of irritable bowel syndrome patients.
    Wang YM; Chang Y; Chang YY; Cheng J; Li J; Wang T; Zhang QY; Liang DC; Sun B; Wang BM
    Neurogastroenterol Motil; 2012 Jun; 24(6):560-5, e254-5. PubMed ID: 22435794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome.
    Jin DC; Cao HL; Xu MQ; Wang SN; Wang YM; Yan F; Wang BM
    World J Gastroenterol; 2016 Sep; 22(36):8137-48. PubMed ID: 27688655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism.
    Barbaro MR; Di Sabatino A; Cremon C; Giuffrida P; Fiorentino M; Altimari A; Bellacosa L; Stanghellini V; Barbara G
    Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G439-47. PubMed ID: 26744473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-144 Increases Intestinal Permeability in IBS-D Rats by Targeting OCLN and ZO1.
    Hou Q; Huang Y; Zhu S; Li P; Chen X; Hou Z; Liu F
    Cell Physiol Biochem; 2017; 44(6):2256-2268. PubMed ID: 29258088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of oculo-acupuncture therapy on colonic serotonin reuptake transporter expression in rats with irritable bowel syndrome].
    Song SY; Wang YJ; Wang DS; Chai JY
    Zhen Ci Yan Jiu; 2011 Apr; 36(2):101-4, 115. PubMed ID: 21717776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of serotonin reuptake transporter gene expression in healing colonic mucosa in presence of remaining low-grade inflammation in ulcerative colitis.
    Tada Y; Ishihara S; Kawashima K; Fukuba N; Sonoyama H; Kusunoki R; Oka A; Mishima Y; Oshima N; Moriyama I; Yuki T; Ishikawa N; Araki A; Harada Y; Maruyama R; Kinoshita Y
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1443-52. PubMed ID: 26676714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal Serotonin Reuptake Transporter Expression in Irritable Bowel Syndrome Is Modulated by Gut Microbiota Via Mast Cell-Prostaglandin E2.
    Gao J; Xiong T; Grabauskas G; Owyang C
    Gastroenterology; 2022 Jun; 162(7):1962-1974.e6. PubMed ID: 35167867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea.
    Martínez C; Rodiño-Janeiro BK; Lobo B; Stanifer ML; Klaus B; Granzow M; González-Castro AM; Salvo-Romero E; Alonso-Cotoner C; Pigrau M; Roeth R; Rappold G; Huber W; González-Silos R; Lorenzo J; de Torres I; Azpiroz F; Boulant S; Vicario M; Niesler B; Santos J
    Gut; 2017 Sep; 66(9):1537-1538. PubMed ID: 28082316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of
    Cao YN; Feng LJ; Liu YY; Jiang K; Zhang MJ; Gu YX; Wang BM; Gao J; Wang ZL; Wang YM
    World J Gastroenterol; 2018 Jan; 24(3):338-350. PubMed ID: 29391756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor upregulates serotonin transporter and its association with visceral hypersensitivity in irritable bowel syndrome.
    Cui XF; Zhou WM; Yang Y; Zhou J; Li XL; Lin L; Zhang HJ
    World J Gastroenterol; 2014 Oct; 20(37):13521-9. PubMed ID: 25309082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients.
    Kerckhoffs AP; Ter Linde JJ; Akkermans LM; Samsom M
    Neurogastroenterol Motil; 2008 Aug; 20(8):900-7. PubMed ID: 18363639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin and serotonin transporter in the rectum of patients with irritable bowel disease.
    El-Salhy M; Wendelbo I; Gundersen D
    Mol Med Rep; 2013 Aug; 8(2):451-5. PubMed ID: 23778763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin transporter gene (SLC6A4) polymorphism in patients with irritable bowel syndrome and healthy controls.
    Kumar S; Ranjan P; Mittal B; Ghoshal UC
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):31-8. PubMed ID: 22457857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA XIST modulates 5-hydroxytrytophan-induced visceral hypersensitivity by epigenetic silencing of the SERT gene in mice with diarrhea-predominant IBS.
    Zhang Y; Zhang H; Zhang W; Zhang Y; Wang W; Nie L
    Cell Signal; 2020 Sep; 73():109674. PubMed ID: 32446903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetics of the serotonin transporter and irritable bowel syndrome.
    Colucci R; Blandizzi C; Bellini M; Ghisu N; Tonini M; Del Tacca M
    Trends Mol Med; 2008 Jul; 14(7):295-304. PubMed ID: 18550438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation.
    Foley S; Garsed K; Singh G; Duroudier NP; Swan C; Hall IP; Zaitoun A; Bennett A; Marsden C; Holmes G; Walls A; Spiller RC
    Gastroenterology; 2011 May; 140(5):1434-43.e1. PubMed ID: 21315720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338-3p Are Downregulated in Irritable Bowel Syndrome and Are Associated With Barrier Function and MAPK Signaling.
    Mahurkar-Joshi S; Rankin CR; Videlock EJ; Soroosh A; Verma A; Khandadash A; Iliopoulos D; Pothoulakis C; Mayer EA; Chang L
    Gastroenterology; 2021 Jun; 160(7):2409-2422.e19. PubMed ID: 33617890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine.
    Kerckhoffs AP; ter Linde JJ; Akkermans LM; Samsom M
    Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G1053-60. PubMed ID: 22323131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serotonin transporter immunoreactivity intensity in the ileum of patients with irritable bowel disease.
    Wendelbo I; Mazzawi T; El-Salhy M
    Mol Med Rep; 2014 Jan; 9(1):180-4. PubMed ID: 24213511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.